| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $1.32 | $2.97 | $4.24 | $3.58 | $0.36 | $0.52 | $0.68 | $0.10 |
| EPS (Diluted) | $1.32 | $2.97 | $4.23 | $3.57 | $0.36 | $0.51 | $0.67 | $0.10 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.5B | $7.9B | $7.9B | $7.4B | $6.9B | $6.1B | $5.6B | $4.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.2B | $0.7B | $0.3B | $0.4B | $0.2B | $0.2B |
| Total Liabilities | $6.8B | $7.1B | $7.1B | $6.8B | $6.2B | $5.4B | $5.0B | $4.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.7B | $0.8B | $0.8B | $0.7B | $0.6B | $0.7B | $0.6B | $0.4B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.3B | $0.5B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $0.1B | $-0.1B | $-1.1B | $-0.5B | $-1.3B | $0.1B | $-0.0B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.3B | $-0.1B | $0.3B | $0.5B | $0.8B | $0.0B | $-0.1B | $0.2B |